Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 8/20 | 0.39 |
| ▸ | CA1 | P00915 | 6/20 | 0.39 |
| ▸ | CA7 | P43166 | 3/20 | 0.39 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 3/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 2/20 | 0.37 |
| ▸ | ACHE | P22303 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8430301 | 0.88 | CA2 (0.40) | CA2CA1CA7MIFCA4 | |
| SCHEMBL8431937 | 0.84 | MIF (0.44) | CA2CA1CA7MIFCA4 | |
| SCHEMBL8428757 | 0.84 | MIF (0.44) | CA2CA1CA7MIFCA4 | |
| SCHEMBL8431678 | 0.84 | MIF (0.44) | CA2CA1CA7MIFCA4 | |
| SCHEMBL8432320 | 0.83 | CA2 (0.41) | CA2CA1CA7MIFCA4 | |
| SCHEMBL8430256 | 0.83 | CA2 (0.40) | CA2CA1CA7MIFCA4 | |
| SCHEMBL8432426 | 0.82 | CA2 (0.40) | CA2CA1CA7MIFCA4 | |
| SCHEMBL10611496 | 0.82 | CA2 (0.40) | CA2CA1CA7MIFCA4 | |
| SCHEMBL8603397 | 0.80 | AKR1C3 (0.47) | CA2CA1CA7MIFCA4 | |
| SCHEMBL8431752 | 0.77 | CYP19A1 (0.47) | CA2CA1CA7MIFCA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5965619-A | ADMINISTERING AN INDENE DERIVATIVE OF GIVEN FORMULA, SUCH AS 1-(2,4,6-TRIMETHOXYBENZYLIDENE)-5-DIMETHYLAMINO-2-METHYL-3-INDENYL ACETIC ACID, TO TREAT PRECANCEROUS LESIONS SUCH AS COLONIC ADENOMATOUS POLYPS; SIDE EFFECT REDUCTION | CELL PATHWAYS INC. (US) | 1999-10-12 | — | — | US | disclosed |
| EP-0142801-B1 | INDENE DERIVATIVES USEFUL AS PAF-ANTAGONISTS | MERCK & CO. INC. (US) | 1989-05-31 | — | — | EP | disclosed |
| US-4656190-A | PLATELET ACTIVATING FACTOR | MERCK & CO., INC. (US) | 1987-04-07 | — | — | US | disclosed |
| EP-0142801-A2 | Indene derivatives useful as paf-antagonists | MERCK & CO. INC. (US) | 1985-05-29 | — | — | EP | disclosed |